Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited-stage Small Cell Lung Cancer (LS-SCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT05904015
What this trial is testing

The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC

Who this might be right for
Lung Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07637513
What this trial is testing

Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer

Who this might be right for
Limited Stage Small-Cell Lung Cancer
PrECOG, LLC. 430
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07798947
What this trial is testing

A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC

Who this might be right for
Limited-stage Small-cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 120
Post-approval studies (Phase 4)Not Yet RecruitingNCT07485920
What this trial is testing

A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
The Affiliated Hospital of Qingdao University 20
Large-scale testing (Phase 3)Active Not RecruitingNCT03811002
What this trial is testing

Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
Limited Stage Lung Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 544
Testing effectiveness (Phase 2)Looking for participantsNCT06295926
What this trial is testing

Serplulimab Combined With CCRT for LS-SCLC.

Who this might be right for
Small Cell Lung Cancer
Peking Union Medical College Hospital 96
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07357532
What this trial is testing

Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD

Who this might be right for
Small Cell Lung Carcinoma
Peking University Cancer Hospital & Institute 44
Testing effectiveness (Phase 2)Looking for participantsNCT07559786
What this trial is testing

A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy

Who this might be right for
SCLC, Limited Stage
Henan Cancer Hospital 200
Large-scale testing (Phase 3)Looking for participantsNCT06095583
What this trial is testing

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Shanghai Junshi Bioscience Co., Ltd. 756
Large-scale testing (Phase 3)UnknownNCT04691063
What this trial is testing

The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.

Who this might be right for
Small-cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 486
Not applicableLooking for participantsNCT06869239
What this trial is testing

Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Peking University Cancer Hospital & Institute 65
Not applicableStudy completedNCT02394548
What this trial is testing

Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer

Who this might be right for
Non-small Cell Lung CarcinomaSmall Cell Lung Carcinoma
Massachusetts General Hospital 27
Large-scale testing (Phase 3)Active Not RecruitingNCT04624204
What this trial is testing

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

Who this might be right for
Small Cell Lung Cancer
Merck Sharp & Dohme LLC 672
Large-scale testing (Phase 3)Looking for participantsNCT05623267
What this trial is testing

Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT

Who this might be right for
Limited Stage Small Cell Lung Cancer
Sun Yat-sen University 346
Large-scale testing (Phase 3)UnknownNCT02990780
What this trial is testing

Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC

Who this might be right for
SCLC
Shanghai Chest Hospital 266
Early research (Phase 1)Study completedNCT00062322
What this trial is testing

Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Fox Chase Cancer Center